John Cho

John Cho

Company: KSQ Therapeutics

Job title: Director, Immunobiology


Functional Genomic Approaches to Identify Key Regulators of Human Tregs 2:00 pm

Utilizing CRISPR-based functional genomics to harness the therapeutic potential of human Tregs for autoimmunity Overview of in vitro and in vivo systems to identify and validate Treg target Examples of therapeutic applications for Treg targets (e.g., small molecule, large molecule, and cellular therapy approachesRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.